Jeffrey Robert Ajer - Apr 29, 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Commercial Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Apr 29, 2022
Transactions value $
-$82,035
Form type
4
Date filed
5/31/2022, 09:29 PM
Previous filing
Apr 14, 2022
Next filing
Jun 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $21.2K +340 +0.62% $62.41 55.4K Apr 29, 2022 Direct F1
transaction BMRN Common Stock Sale -$103K -1.31K -2.36% $78.94 54.1K May 26, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired by the reporting person on April 29, 2022, pursuant to the issuer's Employee Stock Purchase Plan.
F2 Trade made pursuant to a 10b5-1 plan executed on February 28, 2022.